Infectious Disease Therapeutics Market by Drug, Route of Administration, Disease, Distribution Channel, End-User - Global Forecast 2025-2030- Product Image

Sale

Infectious Disease Therapeutics Market by Drug, Route of Administration, Disease, Distribution Channel, End-User - Global Forecast 2025-2030

Report
198 Pages
October 2024
Region: Global
360iResearch™
ID: 5888743

UP TO €681EUR$697USD£568GBP OFF until Dec 31^st 2024

The Infectious Disease Therapeutics Market grew from USD 116.21 billion in 2023 to USD 121.27 billion in 2024. It is expected to continue growing at a CAGR of 4.41%, reaching USD 157.28 billion by 2030.

The scope of the Infectious Disease Therapeutics market primarily revolves around the development and distribution of treatments aimed at preventing or curing infections caused by bacteria, viruses, fungi, and parasites. This sector is driven by the rising prevalence of infectious diseases globally, necessitating advanced therapeutics to counteract drug-resistant strains and emerging pathogens. Applications of these therapeutics are diverse, spanning hospitals, clinics, and home care settings for treatment and prevention, with end-use markets including public health facilities, individual healthcare providers, and governmental health organizations. Key growth influences include the increasing incidence of chronic and infectious diseases, technological advancements in drug development, and supportive government initiatives for disease eradication. However, limitations such as high drug development costs, stringent regulatory requirements, and the unpredictable nature of pathogen mutation present significant challenges. Despite these hurdles, there are burgeoning opportunities in the form of novel drug delivery systems, personalized medicine, and growing investments in R&D activities. Innovations in vaccine development, specifically mRNA vaccines and nanoparticle-based delivery systems, are highlighted as promising areas for business growth. Furthermore, the integration of AI in drug discovery and diagnostics presents exciting opportunities for efficiency improvements and cost reductions. However, market growth is still constrained by challenges like insufficient healthcare infrastructure in low-income regions and the slow global distribution of vaccines during pandemics. To capitalize on opportunities, companies are recommended to focus on collaborative partnerships for research and the expansion of production capabilities. Additionally, adapting strategies to meet diverse regulatory requirements across different regions can enhance market presence. The nature of the market is dynamic, necessitating continuous innovation and adaptation to swiftly respond to the evolving landscape of infectious disease threats.

Understanding Market Dynamics in the Infectious Disease Therapeutics Market

The Infectious Disease Therapeutics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Growing prevalence of infectious disease across the globe
- Government initiatives and prompt actions to reduce the burden of infectious disease
- Increasing number of patent expirations and entry of generic drugs
Market Restraints
- Adverse health outcomes of infectious disease drugs
Market Opportunities
- Surging investments for development of new drugs to treat infectious diseases
- Recent advances in immunotherapies against infectious disease
Market Challenges
- Availability of alternative treatments for infectious disease management

Exploring Porter’s Five Forces for the Infectious Disease Therapeutics Market

Porter’s Five Forces framework further strengthens the insights of the Infectious Disease Therapeutics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Infectious Disease Therapeutics Market

External macro-environmental factors deeply influence the performance of the Infectious Disease Therapeutics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Infectious Disease Therapeutics Market

The Infectious Disease Therapeutics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Infectious Disease Therapeutics Market

The Infectious Disease Therapeutics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Infectious Disease Therapeutics Market

The Infectious Disease Therapeutics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infectious Disease Therapeutics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alexion Pharmaceuticals, Inc., Allergan PLC, Amgen Inc., Astellas Pharma US, Inc., AstraZeneca PLC, Bayer AG, BioCryst Pharmaceuticals, Inc., Biogen Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Celgene Corporation, Chimerix, Inc., Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Mitsubishi Chemical Group Corporation, Mylan N.V., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., and Takeda Pharmaceutical Co. Ltd..

Market Segmentation & Coverage

This research report categorizes the Infectious Disease Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug
- Antibiotics
- Antifungal Drugs
- Antiparasitic Drugs
- Antiviral Drugs
Route of Administration
- Intravenous
- Oral
- Topical
Disease
- Hepatitis
- HIV
- Influenza
- Malaria
- Tuberculosis
Distribution Channel
- Offline
- Online
End-User
- Homecare Facilities
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of infectious disease across the globe
5.1.1.2. Government initiatives and prompt actions to reduce the burden of infectious disease
5.1.1.3. Increasing number of patent expirations and entry of generic drugs
5.1.2. Restraints
5.1.2.1. Adverse health outcomes of infectious disease drugs
5.1.3. Opportunities
5.1.3.1. Surging investments for development of new drugs to treat infectious diseases
5.1.3.2. Recent advances in immunotherapies against infectious disease
5.1.4. Challenges
5.1.4.1. Availability of alternative treatments for infectious disease management
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Infectious Disease Therapeutics Market, by Drug

6.1. Introduction
6.2. Antibiotics
6.3. Antifungal Drugs
6.4. Antiparasitic Drugs
6.5. Antiviral Drugs

7. Infectious Disease Therapeutics Market, by Route of Administration

7.1. Introduction
7.2. Intravenous
7.3. Oral
7.4. Topical

8. Infectious Disease Therapeutics Market, by Disease

8.1. Introduction
8.2. Hepatitis
8.3. HIV
8.4. Influenza
8.5. Malaria
8.6. Tuberculosis

9. Infectious Disease Therapeutics Market, by Distribution Channel

9.1. Introduction
9.2. Offline
9.3. Online

10. Infectious Disease Therapeutics Market, by End-User

10.1. Introduction
10.2. Homecare Facilities
10.3. Hospitals & Clinics

11. Americas Infectious Disease Therapeutics Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Infectious Disease Therapeutics Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Infectious Disease Therapeutics Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. INFECTIOUS DISEASE THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 7. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. INFECTIOUS DISEASE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. INFECTIOUS DISEASE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. INFECTIOUS DISEASE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. INFECTIOUS DISEASE THERAPEUTICS MARKET DYNAMICS
TABLE 7. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ANTIFUNGAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ANTIPARASITIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ANTIVIRAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY HIV, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY MALARIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY HOMECARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 45. CANADA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 47. CANADA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. CANADA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 50. MEXICO INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. MEXICO INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. CHINA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 72. CHINA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 74. CHINA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. CHINA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. INDIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 77. INDIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 79. INDIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. INDIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 87. JAPAN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 89. JAPAN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. JAPAN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 117. THAILAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 119. THAILAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. THAILAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 133. DENMARK INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 135. DENMARK INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. DENMARK INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 138. EGYPT INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. EGYPT INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 143. FINLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. FINLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 148. FRANCE INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. FRANCE INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 153. GERMANY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. GERMANY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. ITALY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 163. ITALY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 165. ITALY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. ITALY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 178. NORWAY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 180. NORWAY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. NORWAY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. POLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 183. POLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 185. POLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. POLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 188. QATAR INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 190. QATAR INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. QATAR INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 208. SPAIN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 210. SPAIN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. SPAIN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 223. TURKEY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 225. TURKEY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. TURKEY INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM INFECTIOUS DISEASE THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. INFECTIOUS DISEASE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. INFECTIOUS DISEASE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Infectious Disease Therapeutics Market, which are profiled in this report, include:

AbbVie Inc.
Alexion Pharmaceuticals, Inc.
Allergan PLC
Amgen Inc.
Astellas Pharma US, Inc.
AstraZeneca PLC
Bayer AG
BioCryst Pharmaceuticals, Inc.
Biogen Inc.
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Celgene Corporation
Chimerix, Inc.
Eli Lilly and Company
Gilead Sciences, Inc.
GlaxoSmithKline PLC
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Mitsubishi Chemical Group Corporation
Mylan N.V.
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Sanofi S.A.
Takeda Pharmaceutical Co. Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	198
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 121.27 Billion
Forecasted Market Value ( USD ) by 2030	$ 157.28 Billion
Compound Annual Growth Rate	4.4%
Regions Covered	Global
No. of Companies Mentioned	25

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3464EUR$3,545USD£2,892GBP €3849EUR$3,939USD£3,213GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6128EUR$6,272USD£5,116GBP €6809EUR$6,969USD£5,684GBP

Understanding Market Dynamics in the Infectious Disease Therapeutics Market

Exploring Porter’s Five Forces for the Infectious Disease Therapeutics Market

Applying PESTLE Analysis to the Infectious Disease Therapeutics Market

Analyzing Market Share in the Infectious Disease Therapeutics Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Infectious Disease Therapeutics Market

Strategic Recommendations for Success in the Infectious Disease Therapeutics Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Infectious Disease Therapeutics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel

Infectious Disease Therapeutics - Global Strategic Business Report

Global Infectious Disease Therapeutics Market Report 2024

Infectious Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Infectious Disease Therapeutics Market Report and Forecast 2024-2032

About the Infectious Disease Drug Market